Loading...

Carmell Therapeutics Corporation

CTCXW•NASDAQ
Healthcare
Biotechnology
$0.03
$-0.02(-45.40%)

Carmell Therapeutics Corporation (CTCXW) Stock Overview

Explore Carmell Therapeutics Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.8/100

Key Financials

Market Cap558.2K
P/E Ratio-0.06
EPS (TTM)N/A
ROE2.47%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.02

CTCXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Carmell Therapeutics Corporation (CTCXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.06 and a market capitalization of 558.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;